{
    "title": "Chinese clampdown on UK drugs firms intensifies as GlaxoSmithKline admits executives appear to have broken law",
    "url": "https://www.dailymail.co.uk/money/markets/article-2373911/GlaxoSmithKline-admits-executives-appear-broken-law.html",
    "date": "2013-07-22",
    "keywords": [
        "law",
        "corruption",
        "group",
        "china",
        "glaxosmithkline",
        "week",
        "hussain",
        "bribery",
        "scandal",
        "yesterday",
        "ministry",
        "security",
        "investigation",
        "clampdown",
        "mail",
        "gmt",
        "july",
        "email",
        "view",
        "astrazeneca",
        "shanghai",
        "policegsk",
        "abbas",
        "escalating",
        "company",
        "hospital",
        "meeting",
        "securitygsk",
        "situation",
        "tolerance",
        "behaviour",
        "naturehe",
        "share",
        "desire",
        "price",
        "gsk",
        "executive",
        "sir",
        "tomorrow",
        "city",
        "quarter",
        "statementchina",
        "mastermind",
        "travel",
        "money",
        "giant",
        "shamefulmark",
        "companys",
        "manager",
        "country",
        "britain",
        "finance",
        "chief",
        "steve",
        "nechelput",
        "involvement",
        "scandalthe",
        "report",
        "department",
        "justice",
        "wall",
        "exchange",
        "commission",
        "government",
        "chinahowever",
        "bureau",
        "police",
        "matter",
        "representativea",
        "spokesman",
        "case",
        "reason"
    ],
    "category": [
        "money",
        "markets"
    ]
}